7 completed, 3 recruiting, 1 active not recruiting, 1 terminated. 4 Not applicable, 3 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Recruiting 2 |
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Uncontrolled Asthma: new trials by email Literature Review of Uncontrolled Asthma trials Research Report on Uncontrolled Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of GDMT in Uncontrolled Asthma Patients Receiving MHD Inhaled Corticosteroids + Long-acting β2 Agonist Intervention group - Uncontrolled Asthma | Not applicable | Recruiting | AstraZeneca | 540 | 2026-09-05 | 2026-09-24 |
| Exploring the Lived Experience of Young Adults With Severe Asthma one to one interviews and or focus groups - Asthma, Severe Asthma | Recruiting | Manchester University NHS Foundation Trust | 46 | 2024-11-25 | 2025-02-05 | |
| Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study Uncontrolled Asthma | Active not recruiting | AstraZeneca | 9000 | 2024-06-27 | 2026-10-13 | |
| Telemedicine Education for Caregivers and Asthma Control in Children Telemedicine-Based Education, Standard Care (in control arm) - Uncontrolled Asthma, Telemedicine-Based Education | Not applicable | Recruiting | Can Tho University of Medicine and Pharmacy | 64 | 2024-06-05 | 2025-07-08 |
| Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy. Specific immunotherapy (SIT) treatment, Dietary Supplement: ABB C1, Mini-tablets with pork extract - Rhinitis, Allergic Rhinoconjunctivitis | Phase 4 | Completed | Gala Servicios Clinicos S.L. | 60 | 2024-05-29 | 2025-08-29 |
| Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy Experimental: CHF6001 3200 μg, Placebo Comparator: CHF6001 Placebo - Uncontrolled Asthma | Phase 2 | Terminated | Chiesi Farmaceutici S.p.A. | 517 | 2023-11-26 | 2025-12-18 |
| Medication Adherence With Telehealthcare Medication Therapy Management Medication Therapy Management (MTM) Video Telehealthcare, Electronic Adherence Self-Management (EAM) - Uncontrolled Asthma, Young Adults | Not applicable | Completed | Johns Hopkins University | 375 | 2019-11-18 | 2026-06-26 |
| Aspirin for Uncontrolled Asthma Aspirin, Placebo - Uncontrolled Asthma | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 24 | 2019-01-15 | 2022-09-08 |
| Systems Pharmacology Approach to Uncontrolled Pediatric Asthma Pediatric Asthma, Uncontrolled Asthma | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 145 | 2018-01-12 | 2021-04-29 | |
| Evaluation of a Community Pharmacist Managed Asthma Consultation Service Pharmacist led Asthma Management, Pharmacist Intervention (when requested by patient) - Uncontrolled Asthma | Not applicable | Completed | Zahava Rosenberg-Yunger | 19 | 2016-06-01 | 2018-08-28 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma Experimental: Tralokinumab, Placebo - Uncontrolled Asthma | Phase 3 | Completed | AstraZeneca | 856 | 2014-10-30 | 2018-05-15 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma Tralokinumab, Placebo - Uncontrolled Asthma | Phase 3 | Completed | AstraZeneca | 1207 | 2014-06-13 | 2018-08-28 |
Asthma (6) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Respiratory Tract Diseases (1) · Rhinitis (1)
Bronchial Diseases (6) · Hypersensitivity (6) · Hypersensitivity, Immediate (6) · Immune System Diseases (6) · Respiratory Hypersensitivity (6) · Respiratory Tract Diseases (6) · Lung Diseases (5) · Lung Diseases, Obstructive (5) · Infections (1) · Nose Diseases (1) · Otorhinolaryngologic Diseases (1) · Respiratory Tract Infections (1)
Aspirin (1) · Focus Groups (1) · Medication Therapy Management (1) · Pork Meat (1) · Standard of Care (1) · Therapeutics (1) · myotubularin (1) · tralokinumab (1)
AstraZeneca (4) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Assistance Publique - Hôpitaux de Paris (1) · Can Tho University of Medicine and Pharmacy (1) · Chiesi Farmaceutici S.p.A. (1) · Gala Servicios Clinicos S.L. (1) · Johns Hopkins University (1) · Manchester University NHS Foundation Trust (1) · Zahava Rosenberg-Yunger (1)
Spain (4) · Germany (3) · United States (3) · Argentina (2) · Bulgaria (2) · Czechia (2) · Hungary (2) · Italy (2) · Poland (2) · Russia (2) · South Africa (2) · South Korea (2) · Taiwan (2) · Ukraine (2) · United Kingdom (2)
Christopher Brightling, MD (1) · Janet Holbrook, PhD (1) · Juan Antonio Carrillo, Medicine (1) · Kathryn Blake, Pharm.D (1) · Kewu Huang (1) · Ly Cong Tran, MD, MSc (1) · Nghia Quang Bui, MD, PhD (1) · Reynold A Panettieri, M.D. (1) · Robert Wise, MD (1) · Thang Hoang Le, MD (1) · Zahava Rosenberg-Yunger, PhD (1)
PMID 29536781, PMID 29792288, PMID 30649752, PMID 31315668, PMID 33105234
2016 (1), R01HL136945 (1)